Eloxx Pharmaceuticals Inc
Company Overview
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel ribonucleic acid (RNA)-modulating drug candidates that are designed to treat rare and ultra-rare premature stop codon diseases. The company's lead drug candidate, ELX-02, is a small molecule drug candidate designed to restore production of full-length functional proteins.
The company is primarily engaged in research and development activities and has not yet generated any revenue from product sales. Their focus is on developing treatments for genetic diseases including cystic fibrosis and other diseases caused by nonsense mutations.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Eloxx Pharmaceuticals Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.